Skip to main content
Clinical Trials/NCT02407548
NCT02407548CompletedPhase 3

The Effects of Dietary Supplement of Coenzyme Q10 on Dyslipidemia

Sun Yat-sen University1 site in 1 country150 target enrollmentStarted: July 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
Effects of CoQ10 on lipid profile

Study Overview

Brief Summary

In previous study the investigators found that CoQ10 can improve cholesterol efflux from macrophages in cell model, ApoE mice model and small-scale of healthy volunteers. In addition, CoQ10 has strong antioxidant activity and is an essential factor of mitochondria electron transport chain. So the investigators hypothesize that CoQ10 may have some health promotion effect on dyslipidemia, risk factor of atherosclerosis and other cardiovascular diseases. On this purpose, the investigators are going to recruit 150 dyslipidemia patients to supply CoQ10+vitamin E or CoQ10 alone or placebo in different doses for 24 weeks to explore the effects of CoQ10 on cholesterol efflux and lipid profiles on dyslipidemia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •The subjects were considered to have dyslipidemia if they met 2 of the following 4 criteria:
  • •fasting total cholesterol concentration>200 mg/dL,
  • •fasting triglyceride concentration>150mg/dL,
  • •fasting LDL-cholesterol concentrations>100 mg/dL, or
  • •fasting HDL-cholesterol concentrations>40 mg/dL.

Exclusion Criteria

  • •history of CVD or other severe chronic disease or use of any drugs known to affect lipid metabolism.
  • •use any antioxidant such as Vitamin E, vitamin C,Phytochemicals and coenzyme Q10 within two months before trial.
  • •pregnant or lactating women

Arms & Interventions

combined group

Experimental

each coenzyme Q10 vitamin E softgel contain CoQ 10 30mg + vitamin E 16mg; The subjects in this arm take 2 softgels after lunch and supper respectively per day. Total supplementation is 120mgCoQ10 and 64mg vitamin per day. The duration is 24 weeks.

Intervention: coenzyme Q10 vitamin E softgel (Dietary Supplement)

CoQ10 group

Experimental

each softgel contain CoQ 10 30mg; The subjects in this arm take 2 softgels after lunch and supper respectively per day. Total supplementation is 120mgCoQ10 per day. The duration is 24 weeks.

Intervention: coenzyme Q10 softgel (Dietary Supplement)

placebo group

Other

each softgel contain no vitamin E, no CoQ10; The subjects in this arm take 2 softgels after lunch and supper respectively per day. The duration is 24 weeks.

Intervention: placebo softgel (Dietary Supplement)

Outcomes

Primary Outcomes

Effects of CoQ10 on lipid profile

Time Frame: 6 months

Tg, Tc, LDL, HDL, APOA1,APOB

Secondary Outcomes

  • Effects of CoQ10 on blood glucose and insulin(6 mouth)
  • Effects of CoQ10 on oxidative stress and inflammation(6 mouth)

Investigators

Sponsor
Sun Yat-sen University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

zhangpeiwen

PhD candidate

Sun Yat-sen University

Study Sites (1)

Loading locations...

Similar Trials